Supplied as a white to off-white crystalline powder with a purity specification of ≥ 98.0% (HPLC, area%), this heterocyclic building block carries the empirical formula C10H19NO3 and a molecular weight of 201.26 g·mol−1. The substance is catalogued under CAS 170491-63-1 and typically ships in amber glass vials purged with argon to maintain a water content below 0.5% (KF). Storage recommendations derive from accelerated stability studies: the compound remains within specification for 24 months at −20 ± 5 °C in a desiccated environment, while exposure to ambient humidity (> 60% RH) for periods exceeding 8 hours initiates detectable carbamate hydrolysis and formation of the free pyrrolidine, detectable by TLC (silica gel 60 F254, cyclohexane/EtOAc 7:3, ninhydrin stain).
What Distinguishes the tert-Butyl Carbamate from Methyl or Benzyl Analogues in Multi-Step Sequences?
In contrast to the corresponding methyl carbamate, which requires strongly basic saponification conditions or trimethylsilyl iodide for cleavage—conditions incompatible with acid-sensitive tertiary alcohols and certain heterocycles—this N-Boc derivative undergoes rapid deprotection with neat trifluoroacetic acid (TFA) or 4 M HCl in dioxane at 0–25 °C. Kinetic profiling by 1H NMR (DMSO‑d6, 400 MHz) indicates that the deprotection half-life in TFA/CH2Cl2 1:1 v/v at 20 °C is 12 ± 2 min, whereas the benzyl carbamate (Cbz) analogue requires hydrogenolysis over Pd/C (10 wt%, 50 psi H2) in a dedicated Parr shaker vessel, a step that introduces catalyst cost and residual metal compliance concerns under ICH Q3D. The benzyl ester nonetheless finds preference in sequences where global acid lability must be avoided; the Cbz-protected 3-hydroxymethylpyrrolidine retains the hydroxymethyl group unchanged during Boc deprotection elsewhere in the molecule. The methyl ester, with a deprotection endpoint requiring pH > 12, is largely restricted to early-stage intermediate elaboration where epimerization risk is absent.
A further operational difference emerges in scalability. The tert-butyl carbamate’s deprotection off-gases isobutylene and carbon dioxide, which can be safely vented through a bleach scrubber in pilot-plant settings; benzyl deprotection consumes hydrogen and demands explosion-proof infrastructure compliant with ATEX Directive 2014/34/EU. Published data for direct calorimetric comparison of deprotection exotherms is limited, but adiabatic reaction calorimetry (ARC) conducted on structurally analogous N-Boc-pyrrolidines places the onset temperature of autocatalytic decomposition above 120 °C, imparting a comfortable safety margin during ambient-temperature cleavage.
Specifications are verified against a certificate of analysis that includes retention time relative to an authenticated reference standard. Identity is confirmed by 1H and 13C NMR, IR (C=O stretch at 1690 ± 5 cm−1, broad O–H absorption centred at 3420 cm−1), and high-resolution mass spectrometry. Enantiomeric excess for the (R)- and (S)-configured forms is controlled to ≥ 99.0% (chiral HPLC, Chiralpak AD‑H column, n-hexane/isopropanol 90:10, 1.0 mL·min−1, 210 nm).
Application of 3-Hydroxymethyl-Pyrrolidine-1-Carboxylic Acid Ter-Butyl-Ester in Medicinal Chemistry Campaigns
The primary utility lies in its function as a rigid, sp3-rich fragment for introducing a basic amine anchor into lead compounds targeting CNS aminergic GPCRs and ion channels. Its hydroxymethyl handle undergoes clean Mitsunobu inversion with phenols or phthalimide, Jones oxidation to the carboxylic acid (CrO3/H2SO4, acetone, 0 °C), or conversion to the mesylate leaving group, which is sufficiently reactive toward NaN3 in DMF at 60 °C to install an azide for click chemistry. In a published dopamine D3 receptor antagonist programme, (S)-3-hydroxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester was alkylated with 4-(4-chlorophenyl)piperazine under standard Williamson conditions (NaH, THF, 0 °C to rt, 18 h, 82% isolated yield after flash chromatography) to deliver the protected intermediate en route to the hydrochloride salt. The crystalline nature of the Boc derivative permits trituration in cold heptane to upgrade purity to 99.5% prior to amide bond formation, a significant advantage over oily analogues (e.g., the corresponding N-formyl compound) that demand chromatography at every stage.
Simulated process mass intensity (PMI) modelling on a 1 kg batch of the Boc-pyrrolidine alcohol in a multi-purpose 50 L jacketed glass reactor (Büchi Glas Uster) indicates that the exotherm upon NaH addition can be controlled within ΔT < 5 °C by dosing the reagent in 0.25 eq portions at 15-minute intervals while maintaining jacket temperature at −5 °C. No pressure accumulation above 0.1 bar was observed, consistent with the low headspace hydrogen evolution rate.
| Parameter | tert-Butyl carbamate | Benzyl carbamate | Methyl carbamate |
|---|---|---|---|
| Deprotection reagent (lab scale) | TFA/DCM, 4 M HCl/dioxane | H₂, Pd/C, EtOH | NaOH aq./MeOH, Δ |
| Typical deprotection time (25 °C) | 1–4 h | 12–48 h | 6–24 h |
| Residual metal risk (ICH Q3D) | Low | Pd ≤ 10 ppm | Low |
| Free amine storage form | TFA or HCl salt | Free base or HCl salt | Free base |
| Solid-state stability at 25 °C/60% RH | 6 months | 12 months | 24 months |
| Cost index (€/mol, lab grade) | 1.0 (reference) | 0.7–0.9 | 0.4–0.6 |
The tert-butyl ester moiety is stable towards nucleophilic acyl substitution and Grignard reagents at low temperature, permitting functionalization of the hydroxymethyl group without premature unmasking. However, exposure to Lewis acids such as BF3·OEt2 or TMSOTf at concentrations above 0.1 M leads to partial Boc cleavage even at −78 °C; coordination of the carbonyl oxygen to the Lewis acid centre is presumed responsible, a limitation not observed with the more robust tosyl-protected analogue. Thus, transformations requiring stoichiometric BF3·OEt2 are better served by the benzyl carbamate, accepting the consequent deprotection overhead.
When Does Batch-to-Batch Colour Variation Signal a Process Impurity Rather Than Degradation?
Off-white to pale yellow colouration detected upon reception is occasionally traced to residual palladium from an upstream Suzuki coupling step if the pyrrolidine ring is constructed via an intramolecular Heck reaction, rather than to oxidative degradation of the hydroxymethyl group. Elemental analysis by ICP-MS (Agilent 7800) quantifies Pd below the ICH Q3D oral permitted daily exposure of 100 μg/day in batches cleared for GMP campaigns. Where colour is accompanied by a melting point depression greater than 3 °C (pure compound melts at 67–70 °C with decomposition onset at 185 °C by DSC at 10 K·min−1), silica gel plug filtration in ethyl acetate followed by crystallisation from n-heptane/EtOAc (5:1 v/v) restores the specification appearance. For supply chain security, an incoming QC protocol per ISO 9001:2015 clause 8.4.1 specifies rejection criteria: any lot exhibiting HPLC purity below 97.0%, single unknown impurity exceeding 0.5%, or residual solvent above ICH Q3C limits (ethyl acetate ≤ 5000 ppm, heptane ≤ 5000 ppm, dichloromethane ≤ 600 ppm).
In medicinal chemistry laboratories operating under the NIH Chemical Genomics Center guidelines, the compound is routinely dissolved in anhydrous DMSO to a stock concentration of 20 mM and dispensed into 384-well plates, where free-thaw cycles (up to 10) demonstrated < 2% decomposition by LCMS, provided the DMSO is dried over 4 Å molecular sieves (20% w/v, activated at 300 °C for 12 h). Aqueous solubility of the neutral carbamate is low (0.8 mg·mL−1 in phosphate buffer pH 7.4); the hydrochloride salt generated in situ increases solubility to > 25 mg·mL−1.
Packing for intercontinental shipment follows UN 4G fibreboard box specifications with vermiculite cushioning. The compound is classified as non-hazardous under DOT 49 CFR and ADR, but local regulations concerning dust explosion (Kst value 0 bar·m·s−1, St 0) should be consulted when handling quantities exceeding 5 kg. Customs harmonised system code 2933.99 applies.
The free hydroxymethyl group exhibits the anticipated reactivity profile toward acyl chlorides and isocyanates. In a typical preparative procedure documented across multiple pharma process development reports, the alcohol (1.0 eq) in dichloromethane (10 vol) is treated with triethylamine (1.5 eq) and acetyl chloride (1.1 eq) at 0 °C, furnishing the acetate ester in quantitative conversion after 30 min. The acetate, being a liquid at room temperature, is rarely isolated; instead it is telescoped directly into the subsequent Boc deprotection and HATU-mediated amide coupling with Fmoc-protected amino acids. This telescoped process reduces solvent consumption by 40% relative to stepwise isolation, an important factor under the ACS Green Chemistry Institute’s Pharmaceutical Roundtable metrics.